Author:
Florczuk Mateusz,Szpechcinski Adam,Chorostowska-Wynimko Joanna
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference203 articles.
1. Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19. doi: 10.1007/978-3-319-24223-1_1 .
2. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review 1975–2013. In: National Cancer Institute. 2015. http://seer.cancer.gov/csr/1975_2013/ . Accessed Based on November 2015 SEER data submission, posted to the SEER web site, April 2016 accessed: 2.01.2016.
3. Fabbri M. MicroRNAs and cancer: towards a personalized medicine. Curr Mol Med. 2013;13(5):751–6.
4. Saumet A, Mathelier A, Lecellier CH. The potential of microRNAs in personalized medicine against cancers. Biomed Res Int. 2014;2014:642916. doi: 10.1155/2014/642916 .
5. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. doi: 10.1056/NEJMoa1102873 .
Cited by
93 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献